Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics total assets
Total assets on the balance sheet at the end of each period.
Bone Biologics's total assets was $6.43M at Sep 30, 2026. For fiscal 2025 it was $5.80M, up 50.1% from the year before. Over ten years it grew 14.1% a year on average. The highest annual figure on record is $8.50M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.80M | +50.1% |
| FY2024 | Dec 31, 2024 | $3.86M | +3.3% |
| FY2023 | Dec 31, 2023 | $3.74M | -56.0% |
| FY2022 | Dec 31, 2022 | $8.50M | +27.3% |
| FY2021 | Dec 31, 2021 | $6.68M | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $30.83K | -97.0% |
| FY2018 | Dec 31, 2018 | $1.04M | +30.8% |
| FY2017 | Dec 31, 2017 | $795.66K | +13.5% |
| FY2016 | Dec 31, 2016 | $701.14K | -54.7% |
| FY2015 | Dec 31, 2015 | $1.55M | -59.5% |
| FY2014 | Dec 31, 2014 | $3.82M | +764178.2% |
| FY2012 | Oct 31, 2012 | $500 | – |
| FY2011 | Oct 31, 2011 | $0 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.43M | +1.3% |
| Q2 FY2026 | Jun 30, 2026 | $4.44M | -36.6% |
| Q1 FY2026 | Mar 31, 2026 | $4.98M | +57.5% |
| Q4 FY2025 | Dec 31, 2025 | $5.80M | +50.1% |
| Q3 FY2025 | Sep 30, 2025 | $6.35M | +56.2% |
| Q2 FY2025 | Jun 30, 2025 | $7.00M | +119.3% |
| Q1 FY2025 | Mar 31, 2025 | $3.16M | -17.6% |
| Q4 FY2024 | Dec 31, 2024 | $3.86M | +3.3% |
| Q3 FY2024 | Sep 30, 2024 | $4.07M | -18.3% |
| Q2 FY2024 | Jun 30, 2024 | $3.19M | -58.1% |
| Q1 FY2024 | Mar 31, 2024 | $3.84M | -43.4% |
| Q4 FY2023 | Dec 31, 2023 | $3.74M | -56.0% |
| Q3 FY2023 | Sep 30, 2023 | $4.98M | -12.1% |
| Q2 FY2023 | Jun 30, 2023 | $7.62M | +25.1% |
| Q1 FY2023 | Mar 31, 2023 | $6.78M | +1.6% |
| Q4 FY2022 | Dec 31, 2022 | $8.50M | +16114.5% |
| Q2 FY2022 | Jun 30, 2022 | $5.66M | +127409.7% |
| Q1 FY2022 | Mar 31, 2022 | $6.09M | +8462.8% |
| Q4 FY2021 | Dec 31, 2021 | $6.68M | – |
| Q3 FY2021 | Sep 30, 2021 | $52.39K | +652.3% |
| Q2 FY2021 | Jun 30, 2021 | $4.44K | -85.6% |
| Q1 FY2021 | Mar 31, 2021 | $71.17K | -71.5% |
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $6.96K | -99.1% |
| Q4 FY2019 | Dec 31, 2019 | $30.83K | -97.0% |
| Q3 FY2019 | Sep 30, 2019 | $249.35K | -89.4% |
| Q2 FY2019 | Jun 30, 2019 | $266.40K | -29.5% |
| Q1 FY2019 | Mar 31, 2019 | $814.09K | +73.0% |
| Q4 FY2018 | Dec 31, 2018 | $1.04M | +30.8% |
| Q3 FY2018 | Sep 30, 2018 | $2.35M | +40.9% |
| Q2 FY2018 | Jun 30, 2018 | $377.74K | -56.5% |
| Q1 FY2018 | Mar 31, 2018 | $470.50K | -72.3% |
| Q4 FY2017 | Dec 31, 2017 | $795.66K | +13.5% |
| Q3 FY2017 | Sep 30, 2017 | $1.67M | +116.3% |
| Q2 FY2017 | Jun 30, 2017 | $868.39K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $701.14K | – |
| Q3 FY2016 | Sep 30, 2016 | $771.39K | – |
See a number that looks wrong?